Notes - Segment Information, Etc.

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7270714

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
165,600,000,000 JPY
119,901,000,000 JPY
518,000,000 JPY
165,082,000,000 JPY
45,181,000,000 JPY
JPY
165,600,000,000 JPY
172,793,000,000 JPY
662,000,000 JPY
173,455,000,000 JPY
42,295,000,000 JPY
JPY
130,497,000,000 JPY
173,455,000,000 JPY
Transactions with other segments
JPY
4,023,000,000 JPY
5,993,000,000 JPY
5,683,000,000 JPY
1,659,000,000 JPY
-11,676,000,000 JPY
11,676,000,000 JPY
7,879,000,000 JPY
6,398,000,000 JPY
JPY
1,837,000,000 JPY
-14,277,000,000 JPY
6,041,000,000 JPY
14,277,000,000 JPY
Other items
Depreciation
6,586,000,000 JPY
3,510,000,000 JPY
223,000,000 JPY
6,363,000,000 JPY
2,853,000,000 JPY
JPY
6,586,000,000 JPY
4,701,000,000 JPY
200,000,000 JPY
4,901,000,000 JPY
1,920,000,000 JPY
JPY
2,780,000,000 JPY
4,901,000,000 JPY
Increase in property, plant and equipment and intangible assets
24,861,000,000 JPY
16,942,000,000 JPY
261,000,000 JPY
24,252,000,000 JPY
7,310,000,000 JPY
347,000,000 JPY
24,514,000,000 JPY
25,646,000,000 JPY
266,000,000 JPY
26,887,000,000 JPY
17,231,000,000 JPY
973,000,000 JPY
8,415,000,000 JPY
25,913,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.